Cortechs.ai | PETQuant: Neurodegenerative Assessment in Clinical Research
Contact

PETQuant: Neurodegenerative Assessment in Clinical Research

  • Category: Case studies
  • Product: NeuroQuant PET

webinar_thumbnail.pngDr. James Brewer, MD, PhD, Neurologist, UC San Diego, hosted a live webinar from our our San Diego headquarters entitled: PETQuant™: Neurodegenerative Dementia Assessment in Research. Dr. Brewer gave a fascinating and enlightening presentation about using PETQuant in clinical research and covered many topics in the video below, including:

  • Why patient native brain space is important in PET imaging
  • The value of quantifying brain structure volumes (via NeuroQuant®)
  • How PETQuant can simplify the process of interpreting PET scans
  • Several case studies

PETQuant is our recently launched for research only tool that provides brain segmentation using PET imaging studies to quantify subregional tracer binding in native brain space for FDG and Florbetapir.

If you would like more information about using PETQuant in your clinical research, please contact us.

  • Topic: Case studies

More Resources

Cortechs.ai | Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series
  • 3 mins

04/02/2025

Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series

Brain volumetrics play a pivotal role in understanding pediatric neurological development. Explore how NeuroQuant® enhances neuroimaging from ages 3 to 100.

Cortechs.ai | How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology
  • 5 mins

03/31/2025

How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology

What if head CT assessment could be even faster and more accurate? Subtraction maps allow for improved detection and visualization of subtle interval changes.

Cortechs.ai | Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India
  • 2 mins

03/27/2025

Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

We are pleased to announce a strategic partnership with Kryptonite Solutions to distribute our innovative portfolio across India.

Cortechs.ai | Cortechs.ai Announces Strategic Distribution Partnership with Medical Horizons to Expand Presence in Italy, Turkey, and the Middle East
  • 2 mins

03/20/2025

Cortechs.ai Announces Strategic Distribution Partnership with Medical Horizons to Expand Presence in Italy, Turkey, and the Middle East

We are pleased to announce a strategic distribution partnership with Medical Horizons, a premier AI-powered medical device distributor based in Florence, Italy.

Cortechs.ai | Unlocking the Power of AI Imaging in Multiple Sclerosis: How NeuroQuant® MS Enhances Lesion Detection and Monitoring
  • 2 mins

03/18/2025

Unlocking the Power of AI Imaging in Multiple Sclerosis: How NeuroQuant® MS Enhances Lesion Detection and Monitoring

Unlock the power of AI-driven imaging with NeuroQuant® MS—enhancing lesion detection, monitoring, and personalized care for Multiple Sclerosis.

Cortechs.ai | Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health
  • 2 mins

03/09/2025

Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health

AI-driven MRI with NeuroQuant® enhances TBI assessment, tracks recovery, and supports better treatment decisions.

View our insights
Cortechs.ai | PETQuant: Neurodegenerative Assessment in Clinical Research
Cortechs.ai | PETQuant: Neurodegenerative Assessment in Clinical Research

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | PETQuant: Neurodegenerative Assessment in Clinical Research
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top